Catholic University of the Sacred Heart

Italy

Country: Italy

Ownership: Private

Established: 1921-01-01

Employees: -

Market Cap: -

Website: http://www.ucsc.it

Clinical Trials

Metformin in Pregnancy in Women With Polycystic Ovary Syndrome

Not Applicable

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Metformin

First Posted Date: 2012-05-09

Last Posted Date: 2012-05-11

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 60

Registration Number: NCT01594697

Locations: 🇮🇹
Catholic University of Sacred Heart, Rome, Italy

IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Epithelial Cancer Recurrent

Interventions: Procedure: HIPEC

First Posted Date: 2012-05-01

Last Posted Date: 2012-05-01

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 30

Registration Number: NCT01588964

Bariatric Surgery and Reactive Hypoglycemia

Not Applicable

Completed

Conditions: Obesity With Complications
Morbid Obesity
Reactive Hypoglycemia
Bariatric Surgery

Interventions: Procedure: Gastric Bypass
Procedure: Sleeve Gastrectomy

First Posted Date: 2012-04-20

Last Posted Date: 2017-02-07

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 120

Registration Number: NCT01581801

Locations: 🇮🇹
Catholic University School of Medicine, Rome, Italy

Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

Phase 3

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Yasmin;
Drug: Metformin plus Yasmin
Drug: Metformin

First Posted Date: 2012-04-20

Last Posted Date: 2012-04-20

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 99

Registration Number: NCT01581814

Locations: 🇮🇹
Policlinico A. Gemelli, Rome, Italy

VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer

Phase 3

Conditions: Rectal Cancer

Interventions: Other: VSL#3
Other: Placebo

First Posted Date: 2012-04-18

Last Posted Date: 2012-04-18

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 160

Registration Number: NCT01579591

Locations: 🇮🇹
Catholic University of Sacred Heart- Rome-, Rome, Italy

Nasal High-flow Versus Venturi Mask Oxygen Therapy in the Post-extubation Period

Not Applicable

Completed

Conditions: Respiratory Failure

Interventions: Device: Venturi mask
Device: Nasal high-flow

First Posted Date: 2012-04-11

Last Posted Date: 2014-02-28

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 105

Registration Number: NCT01575353

Locations: 🇮🇹
ICU "A. Gemelli" University Hospital, Rome, Italy
🇮🇹
ICU, "Maggiore della Carità", University Hospital, Novara, Italy

Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial

Early Phase 1

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Placebo
Drug: Inositol

First Posted Date: 2012-04-10

Last Posted Date: 2012-04-10

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 70

Registration Number: NCT01574261

Locations: 🇮🇹
Università cattolica S. Cuore, Rome, Italy

Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

Phase 2

Completed

Conditions: Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Enlargement (BPE)

Interventions: Drug: BOTOX

First Posted Date: 2012-03-29

Last Posted Date: 2012-03-29

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 33

Registration Number: NCT01566292

Locations: 🇮🇹
Catholic University of Sacred Heart, Rome, Italy

Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone

Not Applicable

Completed

Conditions: Polycystic Ovary Syndrome
Hirsutism
Menstrual Irregularity

Interventions: Drug: myo-inositol 1500 gr
Drug: myo-inositol 2000 gr + folic acid 200 mcg

First Posted Date: 2012-03-15

Last Posted Date: 2020-07-24

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 50

Registration Number: NCT01555190

Locations: 🇮🇹
Catholic University of Sacred Heart, Rome, Italy

Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence

Not Applicable

Conditions: First Recurrence of Ovarian Cancer

Interventions: Procedure: Secondary citoreduction
Procedure: Hyperthermic intra-peritoneal chemotherapy (HIPEC)

First Posted Date: 2012-02-28

Last Posted Date: 2014-08-22

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 158

Registration Number: NCT01539785

Locations: 🇮🇹
Catholic University of Sacred the Hearth, Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy